Pediatrix Medical (MD) Restructuring Costs (2019 - 2026)

Pediatrix Medical has disclosed Restructuring Costs across 8 years of filings, most recently posting $4.9 million for Q1 2026.

• In Q1 2026, Restructuring Costs fell 25.48% year-over-year to $4.9 million; the TTM figure through Mar 2026 stood at $20.6 million (down 67.0% YoY), while the FY2025 annual figure was $22.3 million, down 65.34% from the prior year.
• Restructuring Costs retreated to $4.9 million in Q1 2026, from $5.9 million in the prior quarter.
• Over the last five years, Restructuring Costs for MD reached as high as $23.6 million in Q4 2024 and fell as low as $977000.0 in Q3 2022.
• The 5-year median for Restructuring Costs is $5.9 million (2025), against an average of $8.6 million.
• Annual changes were most pronounced in 2023 — Restructuring Costs plunged 88.66% — and 2024, when it soared 965.39%.
• A 5-year view of Restructuring Costs shows it stood at $19.6 million in 2022, then sank by 88.66% to $2.2 million in 2023, then soared by 965.39% to $23.6 million in 2024, then tumbled by 75.13% to $5.9 million in 2025, then fell by 16.28% to $4.9 million in 2026.
• According to Business Quant data, Restructuring Costs over the past three periods registered $4.9 million, $5.9 million, and $6.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.